Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Psychol Med ; 46(6): 1135-50, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26690829

RESUMEN

BACKGROUND: The GluN2B subunit of N-methyl-d-aspartate receptors is crucially involved in the physiology of the prefrontal cortex during working memory (WM). Consistently, genetic variants in the GluN2B coding gene (GRIN2B) have been associated with cognitive phenotypes. However, it is unclear how GRIN2B genetic variation affects gene expression and prefrontal cognitive processing. Using a composite score, we tested the combined effect of GRIN2B variants on prefrontal activity during WM performance in healthy subjects. METHOD: We computed a composite score to combine the effects of single nucleotide polymorphisms on post-mortem prefrontal GRIN2B mRNA expression. We then computed the composite score in independent samples of healthy participants in a peripheral blood expression study (n = 46), in a WM behavioural study (n = 116) and in a WM functional magnetic resonance imaging study (n = 122). RESULTS: Five polymorphisms were associated with GRIN2B expression: rs2160517, rs219931, rs11055792, rs17833967 and rs12814951 (all corrected p < 0.05). The score computed to account for their combined effect reliably indexed gene expression. GRIN2B composite score correlated negatively with intelligence quotient, WM behavioural efficiency and dorsolateral prefrontal cortex activity. Moreover, there was a non-linear association between GRIN2B genetic score and prefrontal activity, i.e. both high and low putative genetic score levels were associated with high blood oxygen level-dependent signals in the prefrontal cortex. CONCLUSIONS: Multiple genetic variants in GRIN2B are jointly associated with gene expression, prefrontal function and behaviour during WM. These results support the role of GRIN2B genetic variants in WM prefrontal activity in human adults.


Asunto(s)
Memoria a Corto Plazo , Polimorfismo de Nucleótido Simple , Corteza Prefrontal/fisiopatología , Receptores de N-Metil-D-Aspartato/genética , Adolescente , Adulto , Anciano , Mapeo Encefálico , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Adulto Joven
2.
Public Health ; 139: 22-26, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27340042

RESUMEN

OBJECTIVES: Currently louse-borne relapsing fever (LBRF) is primarily found in limited endemic foci in Ethiopia, Somalia and Sudan; no case of imported LBRF has been reported in Europe in the 9 years prior to 2015. The aim of our paper is to describe a new case of imported LBRF detected in Sicily, Italy, and to review all cases reported in migrants arrived in Europe in the last 10 years. STUDY DESIGN: Mini review of all published cases of louse-borne relapsing fever in Europe in the last 10 years. METHODS: A computerized search without language restriction was conducted using PubMed combining the terms '(louse-borne relapsing fever or LBRF or recurrentis) and (refugee or Europe or migrant)' without limits. Furthermore, the 'Ahead-of-Print Articles' of the top 10 journals (ranked by Impact factor - Web of Science) of Infectious diseases and of Epidemiology were checked. RESULTS: Our search identified 26 cases of LBRF between July and October 2015 in migrants recently arrived in Europe: 8 had been described in Italy; 1 in Switzerland; 2 in the Netherlands; 15 in Germany. We describe data regarding the clinical characteristics, diagnostic methods, therapy and outcome of these patients and of the new case. CONCLUSIONS: LBRF by Borrelia recurrentis should be considered among the clinical hypotheses in migrants presenting with fever, headache, chills, sweating, arthralgia, myalgia, dizziness, nausea and vomiting.


Asunto(s)
Borrelia/aislamiento & purificación , Infestaciones por Piojos/complicaciones , Fiebre Recurrente/diagnóstico , Migrantes , Adulto , Diagnóstico Diferencial , Humanos , Masculino , Sicilia , Somalia/etnología , Migrantes/estadística & datos numéricos
3.
Mycorrhiza ; 24 Suppl 1: S65-72, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24522842

RESUMEN

Mycorrhizal symbiotic plants, soil suitability, temperature, and humidity are, by general consensus, considered decisive factors in truffle production. However, experimental approaches to define the environmental conditions that stimulate formation of truffle primordia and promote their growth to maturity have been lacking. By analysis of data of many atmospheric and soil parameters collected since 2009 within a Tuber melanosporum orchard, the trends of metabolic activity, detected as CO2 production in the soil, have been identified as the most reliable parameter to indicate the 'birth' of the truffle primordia. They seem to be produced when mycelial activity is intense and undergoes water stress, after which it resumes. About 6-18 days after recovery of metabolic activity, we could collect primordia of T. melanosporum. Many die or develop too early and consequently rot or are eaten by insect larvae. These events occur several times during summer and autumn, those that 'sprout' in late summer or later grow steadily and reach maturity. Using a particular ground-penetrating radar (GPR) setup to discriminate truffles, we could identify individual truffles in the soil after they have enlarged to at least 6 mm in diameter and follow their growth in volume and diameter over time. These two instrumental methods (CO2 sensor and GPR), although yet to be improved, open new important perspectives to better understand truffle biology and manage truffle orchards to support the newly acquired demonstration of the fundamental role of host plants for the nutrient transfer to the ectomycorrhiza-mycelium-fruiting body complex of T. melanosporum.


Asunto(s)
Ascomicetos/crecimiento & desarrollo , Micorrizas/crecimiento & desarrollo , Agricultura/métodos , Dióxido de Carbono/análisis , Clima , Cuerpos Fructíferos de los Hongos/crecimiento & desarrollo , Suelo/química , Microbiología del Suelo , Temperatura
4.
Minerva Chir ; 69(1): 47-55, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24675245

RESUMEN

AIM: Postoperative ileus has been considered an inevitable consequence of abdominal surgery. The aim of the study was to investigate the efficacy of same treatments in resolving postoperative ileus in various surgical approaches. METHODS: A total of 360 patients underwent abdominal surgery, and was divided into four groups: videolaparoscopic cholecystectomy, laparotomic colo-rectal surgery, laparotomic Hartmann procedure, laparotomic gastric surgery. In each group, patients received different postoperative treatments: chewing gum, olive oil, both, and water. Each group was compared with a control group. RESULTS: In patients who underwent videolaparoscopic cholecystectomy, median postoperative first passage of flatus and stool in the water group was 10 and 34 hours, respectively (P=0.006, P=0.021) and significantly earlier than in the control group (median postoperative 24 and 72 hours). Postoperative stay for the water group was lower (median day 1, 3rd interquartile 2.5) compared with control (median day 3; 3rd interquartile 7.0, P=0.01). In patients who underwent gastric surgery, median postoperative first passage of stool in the olive oil and chewing gum group was 48 hours, significantly earlier than in the control (median postoperative hour 120, P=0.04). Median time to first passage of flatus and stool was also earlier in the other groups compared with the control group, though this difference was not significant. CONCLUSION: Chewing gum, olive oil or both do not induce a relevant reduction of ileus after surgery. Water may be a safe and inexpensive option in reducing ileus. (United States National Institutes of Health, www.clinicaltrial.gov, number NCT01869231).


Asunto(s)
Colecistectomía Laparoscópica , Procedimientos Quirúrgicos del Sistema Digestivo , Ileus/prevención & control , Complicaciones Posoperatorias/prevención & control , Anciano , Goma de Mascar , Colon/cirugía , Defecación , Ingestión de Alimentos , Femenino , Flatulencia , Motilidad Gastrointestinal , Humanos , Ileus/fisiopatología , Laparotomía , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Aceite de Oliva , Aceites de Plantas/administración & dosificación , Aceites de Plantas/uso terapéutico , Complicaciones Posoperatorias/fisiopatología , Recuperación de la Función , Recto/cirugía , Estómago/cirugía , Agua/administración & dosificación
5.
Respir Physiol Neurobiol ; 307: 103979, 2023 01.
Artículo en Inglés | MEDLINE | ID: mdl-36243292

RESUMEN

Ozone (O3) is one of the most harmful urban pollutants, but its biological mechanisms have not been fully elucidated yet. Human bronchial epithelial cells (HBEpC) and human macrophage cells (differentiated human monocytic cell line) were exposed to O3 at the concentration of 240 µg/m3 (120 ppb), corresponding to the European Union alert threshold. Cell viability, reactive oxygen species (ROS) production, and pro-inflammatory cytokines release (IL-8 and TNF-α) were evaluated. Results indicated that O3 exposure increases ROS production in both cell types and enhances cytokines release in macrophages. O3 stimulated IL-8 and TNF-α in HBEpC when the cells were pretreated with Lipopolysaccharide, used to mimic a pre-existing inflammatory condition. Proteomics analysis revealed that, in HBEpC, O3 caused the up-regulation of aldo-keto reductase family 1 member B10, a recognized critical protein in lung carcinogenesis. In conclusion, our results show that 120 ppb O3 can lead to potential damage to human health suggesting the need for a revision of the actual alert levels.


Asunto(s)
Ozono , Humanos , Ozono/toxicidad , Ozono/metabolismo , Interleucina-8 , Factor de Necrosis Tumoral alfa/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Proteómica , Células Epiteliales/metabolismo , Pulmón/metabolismo , Macrófagos/metabolismo
6.
Proc Natl Acad Sci U S A ; 106(44): 18447-51, 2009 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-19841269

RESUMEN

More than half the world's rainforest has been lost to agriculture since the Industrial Revolution. Among the most widespread tropical crops is oil palm (Elaeis guineensis): global production now exceeds 35 million tonnes per year. In Malaysia, for example, 13% of land area is now oil palm plantation, compared with 1% in 1974. There are enormous pressures to increase palm oil production for food, domestic products, and, especially, biofuels. Greater use of palm oil for biofuel production is predicated on the assumption that palm oil is an "environmentally friendly" fuel feedstock. Here we show, using measurements and models, that oil palm plantations in Malaysia directly emit more oxides of nitrogen and volatile organic compounds than rainforest. These compounds lead to the production of ground-level ozone (O(3)), an air pollutant that damages human health, plants, and materials, reduces crop productivity, and has effects on the Earth's climate. Our measurements show that, at present, O(3) concentrations do not differ significantly over rainforest and adjacent oil palm plantation landscapes. However, our model calculations predict that if concentrations of oxides of nitrogen in Borneo are allowed to reach those currently seen over rural North America and Europe, ground-level O(3) concentrations will reach 100 parts per billion (10(9)) volume (ppbv) and exceed levels known to be harmful to human health. Our study provides an early warning of the urgent need to develop policies that manage nitrogen emissions if the detrimental effects of palm oil production on air quality and climate are to be avoided.


Asunto(s)
Agricultura , Contaminación del Aire/análisis , Arecaceae/fisiología , Nitrógeno/análisis , Ozono/análisis , Aceites de Plantas/análisis , Clima Tropical , Aeronaves , Butadienos/análisis , Geografía , Hemiterpenos/análisis , Monoterpenos/análisis , Óxido Nítrico/análisis , Dióxido de Nitrógeno/análisis , Aceite de Palma , Pentanos/análisis , Ácido Peracético/análogos & derivados , Ácido Peracético/análisis , Factores de Tiempo
7.
Parassitologia ; 49(1-2): 39-41, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18416004

RESUMEN

To evaluate the usefulness of conventional serological methods with western blot assay (WB) in congenital toxoplasmosis diagnosis, we prospectively enrolled in a clinical and serological follow-up all pregnant women with Toxoplasma gondii infection and their offspring, referred to us from October 2004. Western blot and standard serological test were performed on sera collected from mother during pregnancy and from mother and child at birth, at postpartum month 1-3-6-9 and 12. At this point in time, 22 pregnant women and 14 infants have completed the follow-up. 4 newborns were infected and 2 had specific toxoplasmosis anomalies at the birth. In mothers without seroconversion, the WB performed during pregnancy demonstrates the highest accordance with postnatal follow-up whereas in 1 case the negative result of PCR analysis was not confirmed by postnatal observation. The detection of anti-T gondii IgG against 8 kDa accessory antigenic band and against the accessory band included between 35 and 40 kDa band in immunoblot assay was useful for diagnosis of acute phase but did not improve the evaluation of comparative postnatal profile. Althougth few infants have concluded the postnatal follow-up, the preliminary results showed a greater value of using a IgM and IgA WB test than other standard method for the early diagnosis of toxoplasmosis at birth also in child born to treated mothers. The comparative anti-T gondii IgG immunoblot profile of mother and child permitted us to reduce the time of ruling out infection in newborns born to mothers with probable or possible infection and/or when prenatal diagnosis is negative or not performed.


Asunto(s)
Anticuerpos Antiprotozoarios/sangre , Enfermedades Fetales/diagnóstico , Técnicas para Inmunoenzimas/métodos , Complicaciones Infecciosas del Embarazo/diagnóstico , Diagnóstico Prenatal/métodos , Toxoplasmosis Congénita/diagnóstico , Toxoplasmosis/diagnóstico , Adulto , Animales , Anticuerpos Antiprotozoarios/inmunología , Antígenos de Protozoos/inmunología , Western Blotting , Femenino , Enfermedades Fetales/epidemiología , Enfermedades Fetales/parasitología , Estudios de Seguimiento , Humanos , Inmunoglobulina A/sangre , Inmunoglobulina A/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Inmunoglobulina M/sangre , Inmunoglobulina M/inmunología , Recién Nacido , Embarazo , Complicaciones Infecciosas del Embarazo/epidemiología , Estudios Prospectivos , Estudios Seroepidemiológicos , Sicilia/epidemiología , Toxoplasma/inmunología , Toxoplasmosis/epidemiología , Toxoplasmosis Congénita/embriología , Toxoplasmosis Congénita/epidemiología
8.
Transl Psychiatry ; 7(1): e1006, 2017 01 17.
Artículo en Inglés | MEDLINE | ID: mdl-28094815

RESUMEN

Genetic risk for schizophrenia (SCZ) is determined by many genetic loci whose compound biological effects are difficult to determine. We hypothesized that co-expression pathways of SCZ risk genes are associated with system-level brain function and clinical phenotypes of SCZ. We examined genetic variants related to the dopamine D2 receptor gene DRD2 co-expression pathway and associated them with working memory (WM) behavior, the related brain activity and treatment response. Using two independent post-mortem prefrontal messenger RNA (mRNA) data sets (total N=249), we identified a DRD2 co-expression pathway enriched for SCZ risk genes. Next, we identified non-coding single-nucleotide polymorphisms (SNPs) associated with co-expression of this pathway. These SNPs were associated with regulatory genetic loci in the dorsolateral prefrontal cortex (P<0.05). We summarized their compound effect on co-expression into a Polygenic Co-expression Index (PCI), which predicted DRD2 pathway co-expression in both mRNA data sets (all P<0.05). We associated the PCI with brain activity during WM performance in two independent samples of healthy individuals (total N=368) and 29 patients with SCZ who performed the n-back task. Greater predicted DRD2 pathway prefrontal co-expression was associated with greater prefrontal activity and longer WM reaction times (all corrected P<0.05), thus indicating inefficient WM processing. Blind prediction of treatment response to antipsychotics in two independent samples of patients with SCZ suggested better clinical course of patientswith greater PCI (total N=87; P<0.05). The findings on this DRD2 co-expression pathway are a proof of concept that gene co-expression can parse SCZ risk genes into biological pathways associated with intermediate phenotypes as well as with clinically meaningful information.


Asunto(s)
Memoria a Corto Plazo , Corteza Prefrontal/metabolismo , ARN Mensajero/metabolismo , Receptores de Dopamina D2/genética , Esquizofrenia/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antipsicóticos/uso terapéutico , Autopsia , Encéfalo/diagnóstico por imagen , Encéfalo/metabolismo , Encéfalo/fisiopatología , Niño , Preescolar , Femenino , Neuroimagen Funcional , Redes Reguladoras de Genes , Predisposición Genética a la Enfermedad , Humanos , Lactante , Recién Nacido , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Herencia Multifactorial , N-Acetilgalactosaminiltransferasas/genética , Pruebas de Farmacogenómica , Polimorfismo de Nucleótido Simple , Corteza Prefrontal/diagnóstico por imagen , Corteza Prefrontal/fisiopatología , Proteínas Represoras/genética , Esquizofrenia/diagnóstico por imagen , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/fisiopatología , Transcriptoma , Adulto Joven , Polipéptido N-Acetilgalactosaminiltransferasa
9.
Infect Agent Cancer ; 11: 25, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27257433

RESUMEN

BACKGROUND: Intravesical instillation of bacille Calmette-Guérin (BCG) has been established as efficient therapy for superficial bladder carcinoma. Overall, intravesical BCG is well tolerated and results in complications of less than 5 %. However, adverse effects such as granulomatous prostatitis, pneumonitis, hepatitis, sepsis, and hypersensitivity reactions may occur. The reported rate for tuberculous orchitis after BCG intravesical therapy is 0.4 %. FINDINGS: We report a case of monolateral tuberculous orchitis occurring one month after the second course of intravescical instillation of bacille Calmette-Guérin in a patient with proven superficial bladder carcinoma and latent tuberculosis infection. CONCLUSIONS: In our opinion intravesical instillation of BCG should be considered on an individual patient basis, with full patient disclosure of the potentially significant risks. A screening with an intradermal Mantoux before starting the first cycle of BCG instillation should be recommended and isoniazid would be indicated as the treatment for latent tuberculosis infection.

10.
Infez Med ; 13(3): 187-91, 2005 Sep.
Artículo en Italiano | MEDLINE | ID: mdl-16397422

RESUMEN

Geotrichum capitatum, now known as Blastoschizomyces capitatus, can be responsible for several opportunistic infections (systemic infection or localized at lungs, liver, kidney, encephalitis or meningitis) in an immunocompromised host, especially in those patients affected by leukaemia or under immunosuppressive therapies. A 66-year-old woman with polimyosite under steroid and immunosuppressant therapy was hospitalized in ICU for an acute respiratory distress with moderate hypoxaemia and normocapnia. Pulmonary X-ray revealed a bilateral pneumonia. Hypoxaemia became severe 48 hours later and the patient underwent mechanical ventilation and empirical antibiotic therapy. Blood cultures, urine cultures and serological tests were negative, while yeast was identified by Gram's stain of bronchoaspirate. Before identifying the yeasts Fluconazole was added to therapy. At day 5 the clinical conditions remained severe and Candida spp were excluded: so Fluconazole was switched to liposomal Amphotericin B. At day 8 B. capitatus was identified. At day 26 the patient died of refractory respiratory insufficiency. B. capitatus infection is infrequent and its prognosis is severe, with a high mortality rate (>50%). Microbiological diagnosis requires time to characterize the yeast. At present no standard therapy is available although some authors report a good susceptibility to Amphotericin B and Voriconazole (100%), according to NCCLS guidelines.


Asunto(s)
Antifúngicos/uso terapéutico , Blastomyces/aislamiento & purificación , Blastomicosis/diagnóstico , Huésped Inmunocomprometido , Enfermedades Pulmonares Fúngicas/diagnóstico , Anciano , Anfotericina B/uso terapéutico , Blastomicosis/tratamiento farmacológico , Resultado Fatal , Femenino , Fluconazol/uso terapéutico , Humanos , Enfermedades Pulmonares Fúngicas/tratamiento farmacológico , Enfermedades Pulmonares Fúngicas/microbiología , Miositis/tratamiento farmacológico
11.
Clin Infect Dis ; 36(12): 1533-8, 2003 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-12802752

RESUMEN

This study evaluated the level of susceptibility of monocytes and lymphocytes to spontaneously induced and CH11-induced apoptosis in 16 patients with Brucella infection. The expression of some immunological and apoptotic markers was evaluated. Before therapy, monocytes showed a high level of resistance to spontaneously induced or CH11-induced apoptosis in all patients. In patients with acute infection, this resistance persisted for 10-20 days after treatment was initiated, then decreased; in chronically infected patients, it persisted after 45 days of treatment. Lymphocytes were also more resistant to CH11-induced apoptosis. The level of activated CD8(+) T lymphocytes was high in patients with acute infection. The data indicate that the CD95-mediated apoptotic pathway is not involved in CH11 resistance. Lymphocytes are not infected by Brucella, so their resistance to apoptosis may be due to a soluble factor released by infected monocytes. The evaluation of levels of susceptibility to CH11-induced apoptosis in monocytes may be used to test the effectiveness of the therapy.


Asunto(s)
Apoptosis , Brucelosis/patología , Linfocitos/patología , Monocitos/patología , Enfermedad Aguda , Adolescente , Adulto , Anticuerpos Monoclonales/farmacología , Brucella , Brucelosis/inmunología , Brucelosis/metabolismo , Linfocitos T CD8-positivos/inmunología , Niño , Preescolar , Enfermedad Crónica , Humanos , Receptor fas/inmunología , Receptor fas/metabolismo
12.
J Pediatr Endocrinol Metab ; 16(2): 179-83, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12713254

RESUMEN

Recent therapeutic approaches have improved the prognosis of children with HIV. Many new efforts could be involved in their quality of life and therefore could need additional diagnostic strategies. Leptin regulates pubertal development; furthermore a continuous immune stimulus, as in chronic infectious diseases, can enhance leptin's secretion by the action of cytokines such as interleukin (IL)-6. To clarify this role in patients infected with HIV, we assayed leptin and IL-6 and evaluated the influence of HIV severity on its secretion. IL-6 (380.5 +/- 257.6 pg/ml; range: 22-900 pg/ml) showed a significant correlation with leptinemia, HIV-1 RNA, and viremia related to the stage of HIV disease. The difference in leptinemia from a control group (3 +/- 3.2 ng/ml; range: 1-12 ng/ml in HIV patients; 6.72 +/- 8 ng/ml in the controls) did not reach statistical significance, nor did it correlate with pubertal stage, BMI, viremia, CD4 or anti-retroviral therapy. There was a statistically significant correlation between leptinemia and the stage of the HIV disease, and with IL-6 level. We want to stress the role of immunological factors in enhancing leptin secretion.


Asunto(s)
Infecciones por VIH/sangre , Interleucina-6/sangre , Leptina/sangre , Fármacos Anti-VIH/uso terapéutico , Antígenos CD4/sangre , Niño , Preescolar , Ensayo de Inmunoadsorción Enzimática , Femenino , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/virología , VIH-1 , Humanos , Lactante , Masculino , Receptores de Leptina , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Maduración Sexual/fisiología
13.
Infez Med ; 4(4): 217-20, 1996.
Artículo en Italiano | MEDLINE | ID: mdl-12858027

RESUMEN

The authors report 57 cases of Respiratory Syncytial Virus (RSV) lower respiratory tract infection. The diagnosis was performed by detection of specific serum antibodies of IgM class or by direct detection of RSV antigens in nasopharyngeal specimens. Most of the patients were younger than one year. No one had risk factors for severe RSV infection form. All patients recovered. The authors emphasize the difficulties to discriminate between bronchiolitis and interstitial pneumonitis on the basis of the clinical and radiological features.

14.
Infez Med ; 4(1): 41-4, 1996.
Artículo en Italiano | MEDLINE | ID: mdl-14967971

RESUMEN

The tuberculous meningitis is an uncommon but severe complication of the tuberculosis mainly in childhood. Neurological sequelae are frequent and high mortality rate, till now, occurs. We reviewed the medical records of 71 cases and we evaluated the most frequent symptoms before the admission and signs and symptoms on the admission according to prognosis. An early diagnosis and specific anti-tuberculous treatment are essential in order to prevent permanent neurological sequelae and fatal outcome

15.
Clin Microbiol Infect ; 17(5): 722-4, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21521413

RESUMEN

A Pseudomonas aeruginosa highly resistant to carbapenems was isolated in a neonatal intensive care unit in Palermo, Italy. The strain was found to carry a novel VIM-type enzyme, classified as VIM-14. The novel enzyme differs from VIM-4 in a G31S mutation. VIM-14 was harboured in a class 1 integron with a new organization. The integron carried the genes aac7, blaVIM-14, blaOXA-20 and aac4 in that order.


Asunto(s)
Integrones , Unidades de Cuidado Intensivo Neonatal , Pseudomonas aeruginosa/enzimología , Pseudomonas aeruginosa/aislamiento & purificación , beta-Lactamasas/genética , Secuencia de Bases , Carbapenémicos/farmacología , ADN Bacteriano/genética , Farmacorresistencia Bacteriana Múltiple/genética , Humanos , Recién Nacido , Integrones/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética , Análisis de Secuencia de ADN , beta-Lactamasas/metabolismo
16.
Minerva Pediatr ; 59(3): 207-13, 2007 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-17519865

RESUMEN

AIM: In order to assess the consequences of different clinical approaches in the prenatal management of congenital toxoplasmosis, we retrospectively reviewed 58 pregnant women with Toxoplasma seroconversion and prospectively enrolled their 59 infants, referred to us from 1999 to 2004. METHODS: Data on clinical, laboratory and demographic characteristics of the pregnant women were collected. Their children were entered into a 48-month follow-up programme in which clinical, instrumental, ophthalmologic and serologic evaluations were carried out at birth, at 1, 3, 6, 9, 15, 18, 24, 36 and at 48 months of life. Paediatric treatment with Spiramycin alone or alternated with Pyrimethamine-Sulphadiazine was administered according to the different clinical cases. RESULTS: Time of infection was dated in the first trimester for 24 women (41%), in the second trimester for 18 women (31%) and in the third trimester for 16 (28%). In the first trimester of pregnancy 20 of the 24 infected women had undergone amniocentesis, while the test had not been performed on any of the women infected in the third trimester. Serological follow-up revealed that 11 (19%) of the infants had been infected. An alternating regimen with Pyrimethamine-Sulphadoxine was administered to the infected children. All the infants were clinically asymptomatic, and the instrumental follow-up revealed specific toxoplasmosis anomalies in 4/11 infected children. CONCLUSION: Our results highlight issues and problems concerning current prenatal diagnostic tests and the therapeutic approach based on PCR testing of amniotic fluid alone. The incidence of ocular-cerebral lesions observed in children born to women with seroconversion in the third trimester raises questions about the diagnostic and therapeutic approach for these women and their offspring. Paediatric therapeutic protocol, with alternating Pyrimethamine-Sulphadiazine regimen, applied also to asymptomatic children born to women with inadequate prenatal diagnostic management, could prevent severe sequelae.


Asunto(s)
Antiprotozoarios/uso terapéutico , Complicaciones Parasitarias del Embarazo/diagnóstico , Toxoplasmosis Congénita/diagnóstico , Adolescente , Adulto , Amniocentesis , Animales , Antimaláricos/uso terapéutico , Biomarcadores/sangre , Coccidiostáticos/uso terapéutico , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Lactante , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Reacción en Cadena de la Polimerasa , Embarazo , Complicaciones Parasitarias del Embarazo/sangre , Complicaciones Parasitarias del Embarazo/tratamiento farmacológico , Complicaciones Parasitarias del Embarazo/epidemiología , Complicaciones Parasitarias del Embarazo/prevención & control , Trimestres del Embarazo , Estudios Prospectivos , Pirimetamina/uso terapéutico , Estudios Retrospectivos , Sicilia/epidemiología , Sulfadiazina/uso terapéutico , Toxoplasmosis Congénita/sangre , Toxoplasmosis Congénita/tratamiento farmacológico , Toxoplasmosis Congénita/epidemiología , Toxoplasmosis Congénita/prevención & control , Resultado del Tratamiento
17.
Minerva Pediatr ; 58(5): 461-7, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17008857

RESUMEN

AIM: HIV infection and antiretroviral drugs have relevant endocrine implications, affecting growth and pubertal development. Moreover stature impairment cannot depend only on decreased hormonal secretion. METHODS: We studied for 7 years growth, puberty, bone maturation, hormonal secretion [Growth Hormone (GH) basal and after stimulation with Clonidin and Insulin, Insulin-like Growth Factor 1 (IGF-1), Insulin-like Growth Factor Binding Protein 3 (IGFBP-3), FSH, LH- gonadic hormones axis, ACTH, Cortisol, TSH, fT4, T4, T3, anti-thyroid antibodies, Leptin] of 10 HIV-infected children. RESULTS: In 3 patients stature was <-2 SDS in the first 2 years and in prepubertal age, with intervals of improved growth. The weight was >2 SDS in 6 children, <-2 SDS in 1 girl, while the other 3 patients had a weight <-2SDS only in the first 2 years of life. Height growth velocity was >10 degrees Centile all over the years of follow-up in 9 patients, while weight growth velocity was pathological in 5. Leptinemia showed higher levels at the beginning of follow up: 0.82-11.68 ng/L (M+/-DS: 3.29+/-4.15) than at the end of the study: 0.2-3 ng/L (M+/-DS: 1.65+/-1.01). Leptin levels showed a statistically significant correlation with CD4/CD8 count (P: 0.010; r: 0.916) and with the CDC stage (P: 0.006; r: 0.937), meaning a strong link to the severity of the disease. CONCLUSIONS: A good clinical control of HIV infection can guarantee growth within physiological centile in most of HIV-infected children. Over all IGFBP-3 and IGF-1 are good markers of growth, more usable than GH.


Asunto(s)
Infecciones por VIH/sangre , Infecciones por VIH/tratamiento farmacológico , Transmisión Vertical de Enfermedad Infecciosa , Desarrollo Óseo , Niño , Desarrollo Infantil , Preescolar , Femenino , Estudios de Seguimiento , Infecciones por VIH/transmisión , Hormonas/metabolismo , Humanos , Lactante , Masculino , Pubertad
18.
Arch Virol ; 148(3): 547-54, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12607105

RESUMEN

Human cytomegalovirus (HCMV) strains, obtained from immunocompetent and immunocompromised Italian hosts, were typed with glycoprotein B (gB) gene restriction analysis. A predominant circulation of HCMV strains with gB type 2 and 3 was detected in both the immunocompetent host with a primary HCMV infection and the immunocompromised host with or without HCMV disease. No association between gB types and subjects with different risks of developing HCMV disease was found. All four gB genotypes were capable of causing congenital infection in Italian babies, with gB type 1 accounting for 50% of the strains examined in symptomatic infants and a remarkable incidence of gB type 4 viruses.


Asunto(s)
Infecciones por Citomegalovirus/congénito , Infecciones por Citomegalovirus/epidemiología , Citomegalovirus/clasificación , Inmunocompetencia , Huésped Inmunocomprometido , Proteínas del Envoltorio Viral/genética , Trasplante de Médula Ósea/efectos adversos , Citomegalovirus/genética , Infecciones por Citomegalovirus/virología , Genotipo , Infecciones por VIH/complicaciones , Infecciones por VIH/virología , Humanos , Recién Nacido , Trasplante de Riñón/efectos adversos , Reacción en Cadena de la Polimerasa , Mapeo Restrictivo
19.
Minerva Pediatr ; 50(1-2): 15-21, 1998.
Artículo en Italiano | MEDLINE | ID: mdl-9658794

RESUMEN

BACKGROUND: The authors report 1642 measles cases observed from September 1996 to June 1997 at the "G. Di Cristina" Children's Hospital. 34% of patients were hospitalized at the Division of Infectious Diseases. METHODS: The records of children admitted with measles to emergency area were retrospectively collected. The medical records (anamnestic, clinical and laboratory findings) of hospitalized children were obtained from schedules which since 1993 were performed to perspectively collect the exanthematous diseases. International criteria for the definition of measles case were applied. The variables considered were: background, demographic data, seasonal distribution, clinical presentation, complications and days of hospital stay. RESULTS: The results of this research showed that the outbreak involved predominantly infants. The complications accounted for 72% of measles hospitalized cases. Four cases of encephalitis were observed. A total of 1692 days of hospital stay was reported. CONCLUSIONS: These data show the failure in measles control adopted by the Sicilian Region and confirm the difficulties to achieve high percentage of parents participation to the infant recommended vaccination program.


Asunto(s)
Brotes de Enfermedades , Sarampión/epidemiología , Vacunación , Factores de Edad , Niño , Preescolar , Interpretación Estadística de Datos , Humanos , Lactante , Recién Nacido , Italia/epidemiología , Sarampión/prevención & control , Estudios Prospectivos , Estaciones del Año
20.
Minerva Pediatr ; 56(6): 611-7, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15765023

RESUMEN

AIM: In order to study the impact of clinical and diagnostic parameters on the clinical outcome of children with central nervous system tuberculosis (CNS-TB), we retrospectively reviewed all cases of CNS-TB diagnosed over a 32-year period at the Children's Hospital of Palermo, Italy. METHODS: Data were collected with regard to the clinical, laboratory and demographic characteristics of patients, as well as the results of radiological investigations and data on clinical outcome. In relation to the date of introduction of new diagnostic methods (indirect as well direct) and to the change of treatment periods, the authors compared the clinical outcome of patients admitted prior and after 1984. They also classified the patients into 3 different stages of illness according to the severity of the disease on admission. RESULTS: We identified 80 patients with CNS-TB. The mean age of the children was 3 years with 54% of patients younger than 5 years. The contact source was documented in 40 patients (50%). The mean duration of symptoms prior to admission was 22 days (range 5 days - 3 months). Mantoux skin test was positive on admission in 50 patients (62%). CSF smear microscopy and culture were positive in 29% and 45% of patients respectively. PCR for Mycobacterium tuberculosis introduced in 1994 was positive in 11 out of 13 tested patients. Determination of CSF gdT lymphocytes composition applied in 7 patients shows a predominance of Vg9/Vd2 T lymphocytes. Fifteen subjects (19%) died; 11 (13%) suffered from permanent sequelae. The died children and those with permanent sequelae were younger than the others (p<0.05). Prior to 1984, none of the patients were identified during early stage of illness and 4 out of 37 patients with stage II illness died. After 1985, 44% of children were in stage I and 2 out of 4 patients with stage III died (p<0.05). CONCLUSIONS: Stage of disease and young age are still the decisive factors in the clinical outcome of children with CNS-TB. The availability of new advanced methods has improved the identification of patients with CNS-TB in stage I and therefore the possibility of an early treatment of such patients.


Asunto(s)
Tuberculosis del Sistema Nervioso Central , Factores de Edad , Antituberculosos/administración & dosificación , Antituberculosos/uso terapéutico , Niño , Preescolar , Recolección de Datos , Interpretación Estadística de Datos , Femenino , Humanos , Lactante , Italia , Masculino , Mycobacterium tuberculosis/aislamiento & purificación , Estudios Retrospectivos , Factores de Tiempo , Resultado del Tratamiento , Prueba de Tuberculina , Tuberculosis del Sistema Nervioso Central/diagnóstico , Tuberculosis del Sistema Nervioso Central/tratamiento farmacológico , Tuberculosis del Sistema Nervioso Central/mortalidad
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda